Spyre Therapeutics, Inc. (SYRE)
NASDAQ·Healthcare·Biotechnology
$98.40
-1.56%
Mkt Cap $6.20B
Analyst Ratings
Buy
19
Hold
0
Sell
0
Price Target (22 analysts)
$97.64
Range $49.00 – $135.00
Implied Upside
-0.8%
Consensus $97.64 vs current $98.40
NASDAQ·Healthcare·Biotechnology
$98.40
-1.56%
Mkt Cap $6.20B
Buy
19
Hold
0
Sell
0
Price Target (22 analysts)
$97.64
Range $49.00 – $135.00
-0.8%
Consensus $97.64 vs current $98.40